| Schedule of Performance Measured Used by CODM |
The following performance measures were used by the CODM: | | | Quantum Drones | | | Genetic Diagnostic | | | Total | | | | | Three months ended | | | Three months ended | | | Three months ended | | | | | June 30, | | | June 30, | | | June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Operating expenses: | | | | | | | | | | | | | | | | | | | | Sales and marketing | | $ | - | | | $ | - | | | $ | 1,458,470 | | | $ | 857,847 | | | $ | 1,458,470 | | | $ | 857,847 | | | Research and development | | | 4,365,232 | | | | - | | | | 187,789 | | | | 101,278 | | | | 4,553,021 | | | | 101,278 | | | General and administrative | | | 131,455 | | | | - | | | | 3,745,987 | | | | 670,950 | | | | 3,877,442 | | | | 670,950 | | | Total operating expenses | | | 4,496,687 | | | | - | | | | 5,392,246 | | | | 1,630,075 | | | | 9,888,933 | | | | 1,630,075 | | | Other expense | | | - | | | | - | | | | 183,387 | | | | 51,910 | | | | 183,387 | | | | 51,910 | | | Loss from discontinued operations | | | - | | | | - | | | | 944,160 | | | | 1,797,848 | | | | 944,160 | | | | 1,797,848 | | | Net loss | | $ | (4,496,687 | ) | | $ | - | | | $ | (6,519,793 | ) | | $ | (3,479,833 | ) | | $ | (11,016,480 | ) | | $ | (3,479,833 | ) | | | | Quantum Drones | | | Genetic Diagnostic | | | Total | | | | | Six months ended | | | Six months ended | | | Six months ended | | | | | June 30, | | | June 30, | | | June 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Operating expenses: | | | | | | | | | | | | | | | | | | | | Sales and marketing | | $ | - | | | $ | - | | | $ | 1,740,373 | | | $ | 2,018,422 | | | $ | 1,740,373 | | | $ | 2,018,422 | | | Research and development | | | 4,365,232 | | | | - | | | | 214,089 | | | | 190,026 | | | | 4,579,321 | | | | 190,026 | | | General and administrative | | | 131,455 | | | | - | | | | 5,900,827 | | | | 2,167,152 | | | | 6,032,282 | | | | 2,167,152 | | | Total operating expenses | | | 4,496,687 | | | | - | | | | 7,855,289 | | | | 4,375,600 | | | | 12,351,976 | | | | 4,375,600 | | | Other expense | | | - | | | | - | | | | 205,939 | | | | 73,842 | | | | 205,939 | | | | 73,842 | | | Loss from discontinued operations | | | - | | | | - | | | | 3,540,547 | | | | 4,033,282 | | | | 3,540,547 | | | | 4,033,282 | | | Net loss | | $ | (4,496,687 | ) | | $ | - | | | $ | (11,601,775 | ) | | $ | (8,482,724 | ) | | $ | (16,098,462 | ) | | $ | (8,482,724 | ) |
|
| Schedule of Balance Sheet |
| | | Quantum Drones | | | Genetic Diagnostic | | | Corporate | | | Total | | | | June 30, | | | December 31, | | | June 30, | | | December 31, | | | June 30, | | | December 31, | | | June 30, | | | December 31, | | | Balance Sheet | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Total Assets | | $ | 5,626,612 | | | $ | - | | | $ | 4,365,239 | | | $ | 4,625,795 | | | $ | 13,376,044 | | | $ | 701,602 | | | $ | 23,367,895 | | | $ | 5,327,396 | |
|